C&EN’s tabulation follows approvals from the FDA’s Center for Drug Evaluation and Research; therefore, it does not include blood products, gene therapies, vaccines, and other therapies that ...
Proposed changes to this list are open for consultation. Learn about the consultation and how to provide your feedback. The consultation closes on March 8, 2025. Drugs included on the list for ...
Our columnist approves. By Elisa Gabbert Elisa Gabbert’s collections of poetry and essays include, most recently, “Normal Distance” and “Any Person Is the Only Self.” Her On Poetry ...
"The $7.3 billion is the difference between what they are reimbursing themselves and what it is estimated to cost them to acquire the drug," an FTC spokesperson told reporters in a press briefing ...
Drugmakers raised the list prices on 575 name-brand drugs in just the first two days of the new year, according to drug price research firm 46brooklyn. Drugs for diabetes, HIV, cancer saw price ...
Harry Sumnall receives funding from public grant awarding bodies for alcohol and other drugs research, and fees from (international) not-for-profit organisations and government departments for ...
Most of the 35,000 online pharmacies around the world are operating illegally and could be selling dangerous or ineffective drugs, according to the U.S. Trade Representative's annual "notorious ...
SPRINGFIELD – For four years, Ivan Felix has heard over and over how much people miss the local hole-in-the-wall Cajun restaurant that built a following across Western Mass. Felix, the former ...
Creole, a masterful 213-foot schooner once owned ... Thereafter, the Danish Navy took the helm, using the historic schooner to rehabilitate drug addicts — something of a far cry from the ...
Godfrey Otung, spokesperson for the Kenyan-led Multinational Security Support Force in Haiti, said 2025 will not be a "nice" year for the armed gangs who control over 80% of the Haitian capital.
Surely, one of these worthy but relatively unsung AI applications is drug development. Its lifesaving potential would be hard to exaggerate. To explore the status of AI-driven drug development ...